Prescription drug · ANDA
Carvedilol Phosphate NDC 42291-482
Carvedilol phosphate 80 mg/1 · Capsule, Extended release · Oral · AvKARE
NDC codes
FDA NDC Directory| Package NDC | 11-digit (billing) | Package | Copy |
|---|---|---|---|
| 42291-482-30 | 42291048230 | 30 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (42291-482-30)Marketed from Jun 27, 2024 |
How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules
Product information
- Brand name (proprietary)
- Carvedilol Phosphate
- Generic name (nonproprietary)
- carvedilol phosphate
- Active ingredients
- Carvedilol phosphate — 80 mg/1
- Dosage form
- Capsule, Extended release
- Route
- Oral
- Labeler
- AvKARE
- Product type
- Prescription drug
- Marketing category
- ANDA — Abbreviated New Drug Application (generic)Application ANDA 204717
- Marketing start
- Listing expires
- Other FDA classes
- Adrenergic alpha-Antagonists (Mechanism)Adrenergic beta1-Antagonists (Mechanism)Adrenergic beta2-Antagonists (Mechanism)
- Identifiers
- Product ID 42291-482_4a7c3ea5-24e9-8ace-e063-6294a90a879dSPL ID 4a7c3ea5-24e9-8ace-e063-6294a90a879dSPL set ID 1be1b5d2-eb2c-1d02-e063-6294a90adbbaRxCUI 860510, 860516, 860522, 860532UNII EQT531S367
- Pharmacologic class
- alpha-Adrenergic Blocker; beta-Adrenergic Blocker
Billing references
What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.
- HCPCS codeNo match
No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.
- NDC on a medical claim
N442291048230followed by a unit qualifier and the quantityPackage 42291-0482-30. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier
Product label
Label details couldn’t be retrieved right now. Open the label on DailyMed.
Other NDCs under ANDA 204717
Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.
| Product | Strength | Form · route | Labeler | Product NDC |
|---|---|---|---|---|
| Carvedilol Phosphate | Carvedilol phosphate 10 mg/1 | Capsule, Extended releaseOral | Amneal Pharmaceuticals of New York LLC | 0115-1248 |
| Carvedilol Phosphate | Carvedilol phosphate 20 mg/1 | Capsule, Extended releaseOral | Amneal Pharmaceuticals of New York LLC | 0115-1249 |
| Carvedilol Phosphate | Carvedilol phosphate 40 mg/1 | Capsule, Extended releaseOral | Amneal Pharmaceuticals NY LLC | 69238-2579 |
| Carvedilol Phosphate | Carvedilol phosphate 40 mg/1 | Capsule, Extended releaseOral | Amneal Pharmaceuticals of New York LLC | 0115-1250 |
| Carvedilol Phosphate | Carvedilol phosphate 10 mg/1 | Capsule, Extended releaseOral | Amneal Pharmaceuticals NY LLC | 69238-2577 |
| Carvedilol Phosphate | Carvedilol phosphate 20 mg/1 | Capsule, Extended releaseOral | Amneal Pharmaceuticals NY LLC | 69238-2578 |
| Carvedilol Phosphate | Carvedilol phosphate 80 mg/1 | Capsule, Extended releaseOral | Amneal Pharmaceuticals NY LLC | 69238-2580 |
| Carvedilol Phosphate | Carvedilol phosphate 80 mg/1 | Capsule, Extended releaseOral | Amneal Pharmaceuticals of New York LLC | 0115-1251 |
| Carvedilol Phosphate | Carvedilol phosphate 10 mg/1 | Capsule, Extended releaseOral | AvKARE | 42291-479 |
| Carvedilol Phosphate | Carvedilol phosphate 20 mg/1 | Capsule, Extended releaseOral | AvKARE | 42291-480 |
| Carvedilol Phosphate | Carvedilol phosphate 40 mg/1 | Capsule, Extended releaseOral | AvKARE | 42291-481 |